ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd (TAK)

15,60
0,15
(0,97%)
Fermé 07 Juin 10:00PM
15,60
0,00
(0,00%)
Après les heures de négociation: 1:22AM

Takeda Pharmaceutical Company Ltd (TAK) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
15,60
( 0,97% )
Prix Achat
-
Prix Vente
-
Volume échangé
3 514 977
15,46 Fourchette du Jour 15,675
12,99 Plage de 52 semaines 18,895
Cap du marché
Clôture Veille
15,45
Ouverture
15,51
Dernière Transaction
30
@
15.54
Dernière heure de transaction
Volume financier
US$ 54 783 236
VWAP
15,5857
Volume moyen (3 m)
US$ 4 391 667
Actions en circulation
1 579 837 574
Rendement du Dividende (LTM)
200 (3,87%)
Ratio Cours sur Bénéfices
42,78
Bénéfice par action (BPA)
119,64
Chiffre d'affairess (LTM)
4,51T
Bénéfice net (LTM)
191,76B

À propos de Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, onco... Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba Fiber, Recombinate, Hemofil, Immunate, Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-licensing agreements with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaborations with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Institute, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, and Teva Pharmaceutical Industries; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei, Zedira/Dr. Falk Pharma, Exelixi GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, KM Biologics, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics. The company was founded in 1781 and is headquartered in Tokyo, Japan. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Site Web
Siège social
Tokyo, Japan
Fondé
1781
Takeda Pharmaceutical Company Ltd est coté dans le secteur Healthcare de la New York Stock Exchange avec le ticker TAK. Le dernier cours de clôture d'Takeda Pharmaceutical était de US$15,45. Au cours de la dernière année, les actions de Takeda Pharmaceutical ont été négociées dans une fourchette de prix de US$ 12,99 à US$ 18,895.

Takeda Pharmaceutical compte actuellement 1 579 837 574 actions en circulation. La capitalisation boursière d'Takeda Pharmaceutical est de US$24,65 milliard. Takeda Pharmaceutical a un ratio cours/bénéfice (ratio PE) de 42.78.

TAK Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.42-2.6217228464416.0216.0714.84310326515.30702518DR
4-1.06-6.3625450180116.6616.7614.84340123816.14555781DR
12-2.32-12.946428571417.9218.89514.84304792117.12857343DR
261.379.62754743514.2318.89514.16294268216.92987108DR
520.644.2780748663114.9618.89512.99308489715.64670535DR
156-0.45-2.8037383177616.0518.89512.575230102814.91093865DR
260-1.13-6.7543335325816.7318.89512.28239801314.8818875DR

TAK - Frequently Asked Questions (FAQ)

What is the current Takeda Pharmaceutical Company Ltd share price?
The current share price of Takeda Pharmaceutical Company Ltd is US$ 15,60
How many Takeda Pharmaceutical Company Ltd shares are in issue?
Takeda Pharmaceutical Company Ltd has 1 579 837 574 shares in issue
What is the market cap of Takeda Pharmaceutical Company Ltd?
The market capitalisation of Takeda Pharmaceutical Company Ltd is USD 24,65B
What is the 1 year trading range for Takeda Pharmaceutical Company Ltd share price?
Takeda Pharmaceutical Company Ltd has traded in the range of US$ 12,99 to US$ 18,895 during the past year
What is the PE ratio of Takeda Pharmaceutical Company Ltd?
The price to earnings ratio of Takeda Pharmaceutical Company Ltd is 42,78
What is the cash to sales ratio of Takeda Pharmaceutical Company Ltd?
The cash to sales ratio of Takeda Pharmaceutical Company Ltd is 1,79
What is the registered address of Takeda Pharmaceutical Company Ltd?
The registered address for Takeda Pharmaceutical Company Ltd is 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Tokyo, 103-8668
What is the Takeda Pharmaceutical Company Ltd website address?
The website address for Takeda Pharmaceutical Company Ltd is www.takeda.com
Which industry sector does Takeda Pharmaceutical Company Ltd operate in?
Takeda Pharmaceutical Company Ltd operates in the Pharmaceuticals sector

TAK Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock